0001567619-23-001537.txt : 20230131 0001567619-23-001537.hdr.sgml : 20230131 20230131142223 ACCESSION NUMBER: 0001567619-23-001537 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230131 DATE AS OF CHANGE: 20230131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Felicia CENTRAL INDEX KEY: 0001675737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 23571974 MAIL ADDRESS: STREET 1: C/O MACY'S, INC. STREET 2: 151 WEST 34TH STREET CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 4 1 doc1.xml FORM 4 X0306 4 2023-01-31 1 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001675737 Williams Felicia 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 0 0 0 Common Stock 2023-01-31 4 D 0 10274 D 0 D Stock Option (Right to Buy) 15.15 2023-01-31 4 D 0 12000 18.85 D 2028-09-20 Common Stock 12000 0 D Stock Option (Right to Buy) 16.97 2023-01-31 4 D 0 8740 17.03 D 2029-01-04 Common Stock 8740 0 D Stock Option (Right to Buy) 10.46 2023-01-31 4 D 0 17205 23.54 D 2030-01-29 Common Stock 17205 0 D Stock Option (Right to Buy) 21.36 2023-01-31 4 D 0 5796 12.64 D 2031-01-27 Common Stock 5796 0 D Stock Option (Right to Buy) 20.75 2023-01-31 4 D 0 5656 13.25 D 2032-01-26 Common Stock 5656 0 D The shares were disposed of pursuant to the Agreement and Plan of Merger dated as of July 7, 2022 (the "Merger Agreement") by and among the Issuer and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea whereby, immediately prior to the effective time of the merger contemplated therein (the "Effective Time"), all issued and outstanding shares of Issuer common stock were converted into the right to receive $34.00 per share in cash and, when so converted, automatically cancelled. The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment. The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment. The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment. The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment. The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment. /s/ F. Mark Reuter, as Attorney-in-Fact for Felicia Williams 2023-01-31